RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0044-1800928
Epidemiological Data from Patients Who Underwent Colonoscopy from High-Susceptibility Vacancies
Abstract
Objective The objective of this study was to analyze the epidemiological profile of patients to propose measures that facilitate regulation and access to diagnostic imaging exams.
Methods Data were collected from 157 scheduled exams for high-suspicion colonoscopy through regulation systems and electronic medical records from January to December 2023. Results: The data showed a higher rate of appointments among females, particularly in older age groups (71–80 years). There was a high rate of non-attendance on the day of the exam scheduled during the coldest months of the year. The most prevalent biopsy location was the colon region, with a predominance of low-grade adenomas and polyps.
Conclusion Facilitating access to diagnostic imaging exams includes regionalization in scheduling. Monitoring results allows for the tracking of family members, enabling preventive action and early diagnosis.
Author's Contribution
Ana Claudia Martins: contributed to the conception and design of the study, initial writing, methodology, interpretation of results, and critical review of the manuscript.
Vera Lúcia Miranda: contributed to the conception and design of the study, initial writing, and data collection.
Milton Brandão Monteiro Jr: contributed to the conception and design of the study, initial writing, and data collection.
Mayra dos Santos Silva: initial writing, methodology, analysis, and interpretation of results and contribution to the final writing and critical review of the manuscript.
Author Disclaimer
Each author of this manuscript warrants that this Work contains no libelous or unlawful statements and does not infringe or violate the publicity or privacy rights of any third party, libel or slander any third party, contain scandalous, obscene, or negligible prepared information, or infringe or violate any other personal or proprietary right of others. Each author also warrants that all statements contained in the Work purporting to be facts are true, and any formula or instruction contained in the Work will not, if followed accurately, cause any injury, illness, or damage to the user.
Publikationsverlauf
Eingereicht: 21. Juni 2024
Angenommen: 24. Oktober 2024
Artikel online veröffentlicht:
18. Dezember 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
- 2 Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet 2019; 394 (10207): 1467-1480
- 3 Siegel RL, Miller KD, Fedewa SA. et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67 (03) 177-193
- 4 Instituto Nacional de Câncer (Brasil). Estimativa 2023: incidência de câncer no Brasil / Instituto Nacional de Câncer. – Rio de Janeiro: INCA, 2022. 160 p.: il. color. ISBN 978–65–88517–09–3 (versão impressa) ISBN 978–65–88517–10–9 (versão eletrônica) 1. Neoplasias. 2. Epidemiologia. 3. Mortalidade. 4. Estatísticas. 5. Incidência. 6. Brasil. I. Título. CDD 614.5999481
- 5 Oliveira RC, Rêgo MAV. Mortality risk of colorectal cancer in Brazil from 1980 to 2013. Arq Gastroenterol 2016; 53 (02) 76-83
- 6 Danaei G, Ding EL, Mozaffarian D. et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6 (04) e1000058
- 7 Grundmann RT, Meyer F. [Gender-specific influences on incidence, screening, treatment, and outcome of colorectal cancer]. Zentralbl Chir 2013; 138 (04) 434-441
- 8 Campos FGCM, Figueiredo MN, Monteiro M, Nahas SC, Cecconello I. Incidence of colorectal cancer in young patients. Rev Col Bras Cir 2017; 44 (02) 208-215
- 9 Kuipers EJ, Grady WM, Lieberman D. et al. Colorectal cancer. Nat Rev Dis Primers 2015; 1: 15065
- 10 Wolf AMD, Fontham ETH, Church TR. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018; 68 (04) 250-281
- 11 Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer 2018; 119 (07) 785-792
- 12 Schreuders EH, Ruco A, Rabeneck L. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015; 64 (10) 1637-1649
- 13 Arditi C, Peytremann-Bridevaux I, Burnand B. et al; EPAGE II Study Group. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. Endoscopy 2009; 41 (03) 200-208
- 14 Zauber AG, Winawer SJ, O'Brien MJ. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366 (08) 687-696 . Long-term follow-up of the National Polyp Study, showing the persistently lower mortality of colorectal cancer after colonoscopy with adenoma removal
- 15 Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von Stillfried D, Schmiegel W. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142 (07) 1460-7.e2
- 16 Muzi CD, Banegas MP, Guimarães RM. Colorectal cancer disparities in Latin America: Mortality trends 1990-2019 and a paradox association with human development. PLoS One 2023; 18 (08) e0289675
- 17 World Health Organization (WHO). Cancer Control. Knowledge into ation. Early Detection (module 3). WHO guide for efective pogrammes. Switzerland: WHO; 2007
- 18 Lei Federal n° 13.896, de 30 de outubro de 2019. Disponível em: https://legis.senado.leg.br/sdleggetter/documento?dm=8033403&ts=1594015859771&disposition=inline#:∼:text=LEI%20N%C2%BA%2013.896%20%2C%20DE%2030,no%20caso%20em%20que%20especifica.&text=Art.,-2%C2%BA%20Esta%20Lei
- 19 Deliberação CIB. n° 53, 21–05–2021. Disponivel em: https://ses.sp.bvs.br/wp-content/uploads/2021/05/E_DL-CIB-53_210521.pdf
- 20 Oliveira Oliveira. et al. Retrospective Analysis of 504 Colonoscopies. Retrospective Analysis of 504 Colonoscopies. Rev Bras Coloproctol •••; 30 (02) 175-182
- 21 Cepellos VM. Feminization of aging: A multifaceted phenomenon beyond the numbers. Rev. adm. empres 2021; 61 (02)
- 22 Hultcrantz R. Aspects of colorectal cancer screening, methods, age and gender. J Intern Med 2021; 289 (04) 493-507
- 23 Izecksohn MMV, Ferreira JT. Falta às consultas médicas agendadas: percepções dos usuários acompanhados pela Estratégia de Saúde da Família, Manguinhos, Rio de Janeiro. Rev Bras Med Fam Comunidade 2014; 9 (32) 235-241
- 24 Santos Santos. et al. Análise dos pólipos colorretais em 3.491 videocolonoscopias. Rev bras. colo-proctol 2008; 28 (03) 299-305
- 25 Seitz U, Bohnacker S, Seewald S. et al. Is endoscopic polypectomy an adequate therapy for malignant colorectal adenomas? Presentation of 114 patients and review of the literature. Dis Colon Rectum 2004; 47 (11) 1789-1796 , discussion 1796–1797
- 26 Bond JH. Interference with the adenoma-carcinoma sequence. Eur J Cancer 1995; 31A (7-8): 1115-1117
- 27 Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39 (09) 846-851
- 28 Instituto Nacional De Câncer José Alencar Gomes Da Silva (INCA). Detecção precoce do câncer. – Rio de Janeiro: INCA; 2021
- 29 Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Rastreamento (Série A: Normas e Manuais Técnicos. Cadernos de Atenção Primária n°29). Brasília; 2010.